News

Eizo Corp. and Stryker Corp. announced their partnership to offer customers integrated large monitor management systems suitable for use in standard and hybrid operating rooms. As a...

Physicians at the Heart Hospital of Austin, enrolled and successfully treated the first patient in the Roadster study, a global, multicenter ...

Cath lab IMV market report

Purchasing activity for cardiac catheterization labs in the United States appears to be growing as more...

Immediate U.S. government furloughs affecting virtually all National Science Foundation (NSF) employees and three-fourths of those at the National Institutes of Health (NIH) could impact U.S....

Enabler-C, EndoCross, enabler catheter

EndoCross, Ltd. announced today that it has already enrolled one-third of the patients planned for the first-in-human study of its Enabler-C Catheter System for Crossing Coronary Chronic Total...

blood testing cath lab beckman coulter danaher

Delivering the precision, clinical sensitivity and clinical specificity necessary to assist physicians with the diagnosis of myocardial infarction (MI), Beckman Coulter Inc. announced the U.S...

Radial access cath lab bethesda transradial artery

While 95 percent of cardiac catheterizations in the United States are done through the groin, physicians at Bethesda Heart Hospital are utilizing special training to offer patients a safer, more...

Cath Lab pharmaceuticals clinical trial study CNIC spain icahn heart attack

Early treatment of heart attack patients with an inexpensive beta-blocker drug called metoprolol, while in transit to the hospital, can significantly reduce damage to the heart during a...

Sapien, TAVR, hybrid OR

As a cutting-edge technique, many hospitals around the country are investigating the development of their own TAVR programs. Starting a TAVR program requires a collaborative commitment to care and...

stents cath lab FDA update guidance delivery system

The U.S. Food and Drug Administration (FDA) released a draft of its proposed updates for the non-clinical engineering tests and recommended labeling for intravascular ...

stent peripheral artery disease treatment complete se medtronic

Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Complete...

Esaote eHD Technology Cardiovascular Ultrasound RSNA 2013

Clinicians face the challenge of effectively imaging larger patients. Recognizing this trend, Esaote’s new eHD Technology improves every element of the imaging chain and increases ultrasound’s...

The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013...

Whole-body magnetic resonance imaging (MRI) may serve as a valuable noninvasive tool for assessing the risk of heart attack and stroke in diabetic patients, according to a new...

Sunshine Heart Inc. has launched a website dedicated to providing information to patients suffering from moderate to severe heart...

Discovery IGS 730

At RSNA 2013, GE Healthcare will highlight the latest hardware and advanced applications for its Discovery IGS angiography platform. These updates are geared towards addressing the challenges of...

CardioLogical Solutions announced that it has been issued two additional patents for its family of aortic embolic protection devices designed to prevent stroke and other ischemic complications....

Patient enrollment has been initiated in a post-market registry for the COMBO Dual Therapy Stent to evaluate its long-term safety and performance in routine clinical practice. The...

JenaValve, TAVI system, heart valve repair, CE Mark, JenaValve CE Mark

JenaValve Technology, Inc. announced that it has raised $62.5 million in a Series C venture round.

Rox Medical has crossed the halfway point in the CONTROL-HTN international, multi-center, randomized controlled hypertension trial. The milestone was met with the enrollment of the first patient...